DE69203194T2 - Thiazolidine-2,4-dione für die Behandlung der Hypertonie. - Google Patents

Thiazolidine-2,4-dione für die Behandlung der Hypertonie.

Info

Publication number
DE69203194T2
DE69203194T2 DE69203194T DE69203194T DE69203194T2 DE 69203194 T2 DE69203194 T2 DE 69203194T2 DE 69203194 T DE69203194 T DE 69203194T DE 69203194 T DE69203194 T DE 69203194T DE 69203194 T2 DE69203194 T2 DE 69203194T2
Authority
DE
Germany
Prior art keywords
hypertension
thiazolidine
dione
treatment
choh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69203194T
Other languages
English (en)
Other versions
DE69203194D1 (de
Inventor
Eric Robert Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69203194D1 publication Critical patent/DE69203194D1/de
Application granted granted Critical
Publication of DE69203194T2 publication Critical patent/DE69203194T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Removal Of Specific Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69203194T 1991-09-25 1992-09-14 Thiazolidine-2,4-dione für die Behandlung der Hypertonie. Expired - Fee Related DE69203194T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/765,643 US5175179A (en) 1991-09-25 1991-09-25 Method for treating hypertension

Publications (2)

Publication Number Publication Date
DE69203194D1 DE69203194D1 (de) 1995-08-03
DE69203194T2 true DE69203194T2 (de) 1995-11-02

Family

ID=25074097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69203194T Expired - Fee Related DE69203194T2 (de) 1991-09-25 1992-09-14 Thiazolidine-2,4-dione für die Behandlung der Hypertonie.

Country Status (17)

Country Link
US (1) US5175179A (de)
EP (1) EP0534655B1 (de)
JP (1) JPH05194220A (de)
KR (1) KR950013756B1 (de)
AT (1) ATE124259T1 (de)
AU (1) AU644545B2 (de)
CA (1) CA2078901A1 (de)
DE (1) DE69203194T2 (de)
DK (1) DK0534655T3 (de)
ES (1) ES2073871T3 (de)
HU (1) HUT65276A (de)
IL (1) IL103202A0 (de)
MX (1) MX9205408A (de)
MY (1) MY129918A (de)
NZ (1) NZ244474A (de)
TW (1) TW209167B (de)
ZA (1) ZA927307B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
ATE462703T1 (de) * 2004-08-25 2010-04-15 Actelion Pharmaceuticals Ltd Bicyclononen-derivate als renin-inhibitoren
JP4297972B2 (ja) * 2005-05-27 2009-07-15 アクテリオン ファーマシューティカルズ リミテッド 新規なピペリジンカルボン酸アミド誘導体
JP2009529033A (ja) * 2006-03-08 2009-08-13 アクテリオン ファーマシューティカルズ リミテッド 新規アミン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
KR0170416B1 (ko) * 1990-02-09 1999-02-18 로버트 에이. 아미테이지 고혈압 치료를 위한 인슐린 증감제의 용도

Also Published As

Publication number Publication date
AU2532692A (en) 1993-04-22
EP0534655B1 (de) 1995-06-28
IL103202A0 (en) 1993-02-21
ATE124259T1 (de) 1995-07-15
JPH05194220A (ja) 1993-08-03
US5175179A (en) 1992-12-29
DK0534655T3 (da) 1995-08-28
TW209167B (de) 1993-07-11
MY129918A (en) 2007-05-31
KR950013756B1 (ko) 1995-11-15
HU9203052D0 (en) 1992-12-28
DE69203194D1 (de) 1995-08-03
ZA927307B (en) 1994-03-24
MX9205408A (es) 1993-03-01
KR930005621A (ko) 1993-04-20
AU644545B2 (en) 1993-12-09
HUT65276A (en) 1994-05-02
EP0534655A1 (de) 1993-03-31
CA2078901A1 (en) 1993-03-26
NZ244474A (en) 1994-01-26
ES2073871T3 (es) 1995-08-16

Similar Documents

Publication Publication Date Title
NO932442D0 (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved behandling av hepatitt b
DE69331643T2 (de) Zwischenprodukte zur Herstellung retroviraler proteasehemmenden Verbindungen
GR3005990T3 (de)
HUT63827A (en) Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same
ATE124259T1 (de) Thiazolidine-2,4-dione für die behandlung der hypertonie.
DE3880564T2 (de) Arzneimittel zur behandlung von herzinsuffizienz.
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
HK1005846A1 (en) Use of imino derivatives of etianaldehyde for the manufacture of a medicament for the treatment of hypertension
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.
DE3782235T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee